Cargando…

Combined Modality Therapies for High-Risk Prostate Cancer: Narrative Review of Current Understanding and New Directions

Despite the many prospective randomized trials that have been available in the past decade regarding the optimization of radiation, hormonal, and surgical therapies for high-risk prostate cancer (PCa), many questions remain. There is currently a lack of level I evidence regarding the relative effica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Greenberger, Benjamin A., Chen, Victor E., Den, Robert B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896415/ https://www.ncbi.nlm.nih.gov/pubmed/31850194 http://dx.doi.org/10.3389/fonc.2019.01273

Ejemplares similares

Mechanistic Insights into Molecular Targeting and Combined Modality Therapy for Aggressive, Localized Prostate Cancer
por: Dal Pra, Alan, et al.
Publicado: (2016)

Editorial: Developing combined modality therapy with mitochondria-targeting strategy
por: Teng, Yong
Publicado: (2023)

Editorial: Advances in the Systemic Therapy and Combined Modality Approaches for Head and Neck Cancer
por: Argiris, Athanassios, et al.
Publicado: (2019)

Obtaining Adequate Surgical Margins in Breast-Conserving Therapy for Patients with Early-Stage Breast Cancer: Current Modalities and Future Directions
por: Pleijhuis, Rick G., et al.
Publicado: (2009)

Precision strikes: PSMA-targeted radionuclide therapy in prostate cancer – a narrative review
por: Szponar, Paweł, et al.
Publicado: (2023)

Combined Modality Approaches in the Management of Adult Glioblastoma
por: Shirazi, Haider A., et al.
Publicado: (2011)

Prostatic Leiomyosarcoma: The Case for Combined Modality Therapy
por: El-Sharkawi, Salah, et al.
Publicado: (1997)

The Impact of Prostate Cancer Treatment on Quality of Life: A Narrative Review with a Focus on Randomized Data
por: Taylor, James M, et al.
Publicado: (2020)

Combining metformin with lactate transport inhibitors as a treatment modality for cancer - recommendation proposal
por: Benjamin, Don, et al.
Publicado: (2022)

Detection of Dominant Intra-prostatic Lesions in Patients With Prostate Cancer Using an Artificial Neural Network and MR Multi-modal Radiomics Analysis
por: Bagher-Ebadian, Hassan, et al.
Publicado: (2019)

Radiation Therapy as a Modality to Create Abscopal Effects: Current and Future Practices
por: Adjepong, Dennis, et al.
Publicado: (2020)

Current Options and Future Directions in Immune Therapy for Glioblastoma
por: Lynes, John, et al.
Publicado: (2018)

Immunosuppression in Glioblastoma: Current Understanding and Therapeutic Implications
por: Himes, Benjamin T., et al.
Publicado: (2021)

Atypical Teratoid Rhabdoid Tumor: Current Therapy and Future Directions
por: Ginn, Kevin F., et al.
Publicado: (2012)

Radiotherapy as a Single Modality in Primary Seminoma of the Prostate
por: Akingbade, Aquila, et al.
Publicado: (2021)

Venetoclax-Based Combinations in Acute Myeloid Leukemia: Current Evidence and Future Directions
por: Samra, Bachar, et al.
Publicado: (2020)

Application of targeted diagnosis of PSMA in the modality shift of prostate cancer diagnosis: a review
por: Yan, Li, et al.
Publicado: (2023)

Current Strategies for Tumor Photodynamic Therapy Combined With Immunotherapy
por: Hua, Jianfeng, et al.
Publicado: (2021)

Stereotactic Body Radiation Therapy (SBRT) as Salvage Therapy for Oligorecurrent Pleural Mesothelioma After Multi-Modality Therapy
por: Schröder, Christina, et al.
Publicado: (2019)

Gliomatosis Cerebri: Current Understanding and Controversies
por: Ranjan, Surabhi, et al.
Publicado: (2017)

Current understanding of the human microbiome in glioma
por: Liang, Jianhao, et al.
Publicado: (2022)

Gastric Cancer With Peritoneal Metastasis—A Comprehensive Review of Current Intraperitoneal Treatment Modalities
por: Prabhu, Aruna, et al.
Publicado: (2022)

Androgen Deprivation Therapy Combined With Particle Therapy for Prostate Cancer: A Systematic Review
por: Petersen, Stine Elleberg, et al.
Publicado: (2021)

Biomarkers to Evaluate Androgen Deprivation Therapy for Prostate Cancer and Risk of Alzheimer’s Disease and Neurodegeneration: Old Drugs, New Concerns
por: Achard, Vérane, et al.
Publicado: (2021)

Combining (68)Ga-PSMA-PET/CT-Directed and Elective Radiation Therapy Improves Outcome in Oligorecurrent Prostate Cancer: A Retrospective Multicenter Study
por: Kirste, Simon, et al.
Publicado: (2021)

Role of PSMA PET-guided metastases-directed therapy in oligometastatic recurrent prostate cancer
por: Alberto, Matthew, et al.
Publicado: (2022)

Recent Advances in Combined Modality Therapy
por: Mierzwa, Michelle L., et al.
Publicado: (2010)

Role of ubiquitin specific proteases in the immune microenvironment of prostate cancer: A new direction
por: Guo, Jinhui, et al.
Publicado: (2022)

New insights into molecular signaling pathways and current advancements in prostate cancer diagnostics & therapeutics
por: Thakur, Neha, et al.
Publicado: (2023)

Long-term outcomes of prostate intensity-modulated radiation therapy incorporating a simultaneous intra-prostatic MRI-directed boost
por: Laughlin, Brady S., et al.
Publicado: (2022)

New Prostate Cancer Targets for Diagnosis, Imaging, and Therapy: Focus on Prostate-Specific Membrane Antigen
por: Cimadamore, Alessia, et al.
Publicado: (2018)

Multifaceted Roles of Asporin in Cancer: Current Understanding
por: Zhan, Shaohua, et al.
Publicado: (2019)

Recent advances in understanding DNA methylation of prostate cancer
por: Shin, Hyun Jin, et al.
Publicado: (2023)

Cetuximab Combined With Sonodynamic Therapy Achieves Dual-Modal Image Monitoring for the Treatment of EGFR-Sensitive Non-Small-Cell Lung Cancer
por: Qiu, Guanhua, et al.
Publicado: (2022)

Spinal metastasis: narrative reviews of the current evidence and treatment modalities
por: Jaipanya, Pilan, et al.
Publicado: (2022)

Narrative review of current neuromodulation modalities for spinal cord injury
por: Medina, Roi, et al.
Publicado: (2023)

Toxicity Reduction in the Treatment of HPV Positive Oropharyngeal Cancer: Emerging Combined Modality Approaches
por: Deschuymer, Sarah, et al.
Publicado: (2018)

Treatment Outcomes of Rare Retromolar Trigone Squamous Cell Carcinoma Using Combined Modalities
por: Faisal, Muhammad, et al.
Publicado: (2017)

Comparison of Current Systemic Combination Therapies for Metastatic Hormone-Sensitive Prostate Cancer and Selection of Candidates for Optimal Treatment: A Systematic Review and Bayesian Network Meta-Analysis
por: Chen, Junru, et al.
Publicado: (2020)

Phase II Study of ENZAlutamide Combined With Hypofractionated Radiation Therapy (ENZART) for Localized Intermediate Risk Prostate Cancer
por: Lara, Pedro C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dcco8ng4nk5rpc0ctb9q23miaj